We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $514.38, moving -0.18% from the previous trading session. This move lagged the S&P 500's daily gain of 1.5%. At the same time, the Dow added 1.12%, and the tech-heavy Nasdaq gained 0.16%.
Coming into today, shares of the largest U.S. health insurer had gained 4.41% in the past month. In that same time, the Medical sector lost 0.3%, while the S&P 500 lost 6.54%.
Wall Street will be looking for positivity from UnitedHealth Group as it approaches its next earnings report date. This is expected to be July 15, 2022. In that report, analysts expect UnitedHealth Group to post earnings of $5.25 per share. This would mark year-over-year growth of 11.7%. Meanwhile, our latest consensus estimate is calling for revenue of $79.67 billion, up 11.71% from the prior-year quarter.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $21.76 per share and revenue of $320.9 billion. These results would represent year-over-year changes of +14.41% and +11.58%, respectively.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. UnitedHealth Group is holding a Zacks Rank of #3 (Hold) right now.
Valuation is also important, so investors should note that UnitedHealth Group has a Forward P/E ratio of 23.69 right now. This valuation marks a premium compared to its industry's average Forward P/E of 16.34.
It is also worth noting that UNH currently has a PEG ratio of 1.6. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. UNH's industry had an average PEG ratio of 1.08 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 29, putting it in the top 12% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $514.38, moving -0.18% from the previous trading session. This move lagged the S&P 500's daily gain of 1.5%. At the same time, the Dow added 1.12%, and the tech-heavy Nasdaq gained 0.16%.
Coming into today, shares of the largest U.S. health insurer had gained 4.41% in the past month. In that same time, the Medical sector lost 0.3%, while the S&P 500 lost 6.54%.
Wall Street will be looking for positivity from UnitedHealth Group as it approaches its next earnings report date. This is expected to be July 15, 2022. In that report, analysts expect UnitedHealth Group to post earnings of $5.25 per share. This would mark year-over-year growth of 11.7%. Meanwhile, our latest consensus estimate is calling for revenue of $79.67 billion, up 11.71% from the prior-year quarter.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $21.76 per share and revenue of $320.9 billion. These results would represent year-over-year changes of +14.41% and +11.58%, respectively.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. UnitedHealth Group is holding a Zacks Rank of #3 (Hold) right now.
Valuation is also important, so investors should note that UnitedHealth Group has a Forward P/E ratio of 23.69 right now. This valuation marks a premium compared to its industry's average Forward P/E of 16.34.
It is also worth noting that UNH currently has a PEG ratio of 1.6. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. UNH's industry had an average PEG ratio of 1.08 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 29, putting it in the top 12% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.